Sandoz Group (SDZNY) News Today $45.94 +1.32 (+2.96%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Sandoz Group (OTCMKTS:SDZNY) Stock Price Down 1% - Here's What HappenedSandoz Group (OTCMKTS:SDZNY) Stock Price Down 1% - Should You Sell?January 18 at 4:39 AM | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Shares Down 1% - Should You Sell?Sandoz Group (OTCMKTS:SDZNY) Shares Down 1% - Here's What HappenedJanuary 18 at 4:39 AM | marketbeat.comSandoz Group: Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 14, 2025 | finanznachrichten.deSandoz: Global Generics And Biosimilars Market To Grow At 7% Annual Compound Rate For Next 10 YearsJanuary 14, 2025 | markets.businessinsider.comSandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 14, 2025 | globenewswire.comSandoz Group (OTCMKTS:SDZNY) Shares Up 1% - Here's WhySandoz Group (OTCMKTS:SDZNY) Trading Up 1% - Here's WhyDecember 27, 2024 | marketbeat.comSandoz Boss Warns There’s a Climate Cost of Obesity Wonder DrugsDecember 21, 2024 | bloomberg.comSandoz Agrees on $275 Million Settlement in U.S. Price-Fixing CaseDecember 19, 2024 | msn.comSandoz Agrees 275 Mn Settlement Of US Class ActionDecember 17, 2024 | barrons.comSandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action LitigationDecember 17, 2024 | markets.businessinsider.comSandoz To Pay $275 Mln To Resolve US Generic Drug Litigation, Plans $265 Mln Provision; Backs ViewDecember 17, 2024 | markets.businessinsider.comSandoz Charts Path to Swift Generic Ozempic Launch in CanadaDecember 11, 2024 | financialpost.comSandoz Group (OTC:SDZNY) Stock Quotes, Forecast and News SummaryDecember 4, 2024 | benzinga.comSandoz Group (OTCMKTS:SDZNY) Trading Up 0.8% - Should You Buy?Sandoz Group (OTCMKTS:SDZNY) Trading 0.8% Higher - Still a Buy?November 26, 2024 | marketbeat.comAgomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of DirectorsNovember 18, 2024 | businesswire.comSandoz receives EC approval for AfqlirNovember 16, 2024 | markets.businessinsider.comSandoz : EC Approves Afqlir 2 Mg Vial Kit & Pre-filled Syringe For Intravitreal InjectionNovember 15, 2024 | markets.businessinsider.comSandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolioNovember 15, 2024 | globenewswire.comSandoz price target raised to CHF 36 from CHF 33 at Deutsche BankNovember 6, 2024 | markets.businessinsider.comSandoz price target raised to CHF 39 from CHF 38 at BerenbergNovember 2, 2024 | markets.businessinsider.comSandoz price target raised to CHF 35 from CHF 32 at Morgan StanleyNovember 1, 2024 | markets.businessinsider.comSandoz reports third-quarter and nine-month 2024 salesOctober 30, 2024 | globenewswire.comSDZNY Sandoz Group AG ADROctober 26, 2024 | seekingalpha.comJ.P. Morgan Sticks to Their Buy Rating for Sandoz Group Ltd (SDZXF)October 22, 2024 | markets.businessinsider.comSandoz price target raised to CHF 43 from CHF 36.50 at JPMorganOctober 22, 2024 | markets.businessinsider.comSandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolioOctober 11, 2024 | globenewswire.comSandoz Canada achieves carbon neutral certification for its commercial operationsOctober 7, 2024 | globenewswire.comUnitedHealth Follows Competitors, Replaces Humira with Lower-Cost BiosimilarsSeptember 12, 2024 | benzinga.comKepler Capital Keeps Their Buy Rating on Sandoz Group Ltd (SDZXF)September 6, 2024 | markets.businessinsider.comSandoz Plans First GLP1 Generic Drug Launch in Canada in 2026September 3, 2024 | bloomberg.comIntroducing Jubbonti® and Wyost®, the first denosumab biosimilars on the Canadian marketAugust 13, 2024 | theglobeandmail.comUK to See First Inflation Rise This Year, Bolstering BOE CautionAugust 12, 2024 | uk.finance.yahoo.comSandoz Group: Sandoz receives FDA approval for Enzeevu (aflibercept-abzv), further strengthening US biosimilar positionAugust 12, 2024 | finanznachrichten.deSandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar positionAugust 12, 2024 | globenewswire.comSandoz Raises Sales Growth Target as Copycat Drugs FlourishAugust 8, 2024 | bloomberg.comSandoz Group AG (SDZNY) Q2 2024 Earnings Call TranscriptAugust 8, 2024 | seekingalpha.comSandoz Group: Sandoz reports second-quarter sales and half-year 2024 resultsAugust 8, 2024 | finanznachrichten.deSandoz H1 Profit Down; Lifts FY24 Sales View, Backs Core Margin Forecast; Names New ExecutivesAugust 8, 2024 | markets.businessinsider.comSandoz reports second-quarter sales and half-year 2024 resultsAugust 8, 2024 | globenewswire.comSandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseasesJuly 25, 2024 | globenewswire.comSandoz Group AGJuly 19, 2024 | wsj.com3 Spinoff Stocks You Should Buy Now: July 2024July 15, 2024 | investorplace.comFDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in USJuly 1, 2024 | globenewswire.comSandoz Gets European Marketing Approval for Osteoporosis, Bone Disease TreatmentsMay 22, 2024 | marketwatch.comSandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in EuropeMay 22, 2024 | globenewswire.comEx-Sandoz exec gets probation for price-fixing after cooperation dealMay 15, 2024 | reuters.comBiosimilars Boosts Sandoz Q1 Sales; Backs Annual Sales OutlookMay 7, 2024 | markets.businessinsider.comSandoz reports first quarter 2024 salesMay 7, 2024 | globenewswire.comSandoz Group AG goes ex dividend tomorrowMay 2, 2024 | msn.comSandoz Reaches Agreement With Amgen Resolving All Patent LitigationApril 30, 2024 | marketwatch.com Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SDZNY Media Mentions By Week SDZNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SDZNY News Sentiment▼0.360.63▲Average Medical News Sentiment SDZNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SDZNY Articles This Week▼21▲SDZNY Articles Average Week Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HNHPF News ITOCY News MURGY News KDDIY News SHECY News CNSWF News BCMXY News VCISY News CMPGY News GLNCY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SDZNY) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sandoz Group AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Sandoz Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
